Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones: Initial results

Heart

Volumn 75, Issue 6, 1996, Pages 596-601

  Mirić, Milutin ^a   Vasiljević, Jovan ^a   Bojić, Milovan ^a   Popović, Zoran ^a   Keserović, Nenad ^b   Pešić, Milan ^c  

^a Dedinje Cardiovascular Institute   (Yugoslavia)

^b Inst Immunobiol Virusology Torlak   (Yugoslavia)

^c Inst for Immunol and Thymus Res   (Germany)

Author keywords

Idiopathic dilated cardiomyopathy; Idiopathic myocarditis; Interferon ; Thymic hormones

Indexed keywords

ALPHA INTERFERON; THYMOMODULIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HUMAN; MALE; MYOCARDITIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029896916     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.6.596     Document Type: Article

References (27)

1. Kandolf R, Kirschner P, Ameis D, Canu A, Erdmann E, Schultheiss H-P, et al. Enteroviral heart disease: diagnosis by in situ hybridisation. In: Schultheiss HP, ed. New concepts in viral heart disease. Berlin: Springer-Verlag, 1988; 337-48.
2. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 1987;84:6272-6.
3. Archard L, Freeke C, Richardson P, Meany B, Olsen E, Morgan-Capner P, et al. Persistence of enterovirus RNA in dilated cardiomyopathy: a progression from myocarditis. In: Schultheiss HP, ed. New concepts in viral disease. Berlin: Springer-Verlag, 1988;349-62.
4. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of Coxsackie-B-virus-specific RBA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;i:1120-3.
5. Weiss LM, Liu XF, Chang KL, Billingham ME. Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J Clin Invest 1992; 90:156-9.
6. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992;89:314-8.
7. Aiuti F, Russo G, Carbonari M, Pontesilli O, Fiorilli M. A rational approach for the use of thymic hormones in viral infection and primary immunodeficiencies. In: Hesch RD, ed. Peptide hormones as mediators in immunology and oncology. Serono Symposia Vol. 19. New York: Raven Press, 1985;185-9.
8. Oldstone MBA, Buchmeier MJ. Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 1982;300:360-62.
9. Kristensson K, Orvell C, Leestma J, Norrby E. Sendai virus infection in the brains of mice: distribution of viral antigens studied with monoclonal antibodies. J Infect Dis 1983;147:297-301.
10. Oldstone MBA, Fujinami RS, Lampert PW. Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. Prog Med Virol 1980;26:45-93.
11. Figulla HR. Idiopathic dilated cardiomyopathy: current concepts in clinical research. In: Figulla HR, Kandolf R, McManus B, eds. Idiopathic dilated cardiomyopathy. Cellular and molecular mechanisms, clinical consequences. Berlin: Springer-Verlag, 1993;3-9.
12. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, et al. Myocarditis: a histological definition and classification. Am J Cardiovasc Pathol 1987;1:3-13.
13. Woodruff JF. Viral myocarditis: a review. Am J Pathol 1980;101:427-9.
14. Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 1982;48:533-4.
15. Disis ML, McDonald TL, Colombo JL, Kobayashi RH, Angle CR, Murray S. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr Res 1986;20:385-90.
16. Kay HD, Fagnani R, Bonnard GD. Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG. Int J Cancer 1979;21:141-50.
17. Hirsch RL, Johnson KP. The effects of long-term administration of recombinant Alpha-2 Interferon on lymphocyte subsets, proliferation, and suppressor cell function in multiple sclerosis. J Interferon Res 1986;6:171-7.
18. Mirić M, Brkić S, Vircburger M, Keserović N, Vučković S, Zdravković M, et al. The effects of interferon-alpha administration on lymphocyte subsets and clinical findings in Coxsackie-virus B induced myocarditis. Iugoslav Physiol Pharmacol Acta 1988;24:257-63.
19. Mirić M, Brkić S, Pešić M, Keserović N, Igrutinović Lj, Kruščić S, et al. Treatment of Coxsackie B induced myocarditis with thymus TFX thymomodulin and interferon-alpha. Period Biol 1990;92:112-3.
20. Maisch B, Herzum M, Schoenian U. Pathogenesis of disease: humans. In: Banatvala JE, ed. Viral infections of the heart. London: Edward Arnold, 1993;138-75.
21. Huber SA. Viral myocarditis: a tale of two diseases. Lab Invest 1992;66:1-3.
22. Benczur M, Petranyi Gy, Varga M, Talas M, Motsy B, Foldes I, et al. Dysfunction of natural killer cells in multiple sclerosis - a possible pathogenetic factor. Clin Exp Immunol 1980;39:657-62.
23. Santoli D, Hall W, Kastrukoff L, Lisak RP, Perussia B, Trinchieri G, et al. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol 1981;126:1274.
24. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269-75.
25. Cohen MC, Muberman MS, Nesto RW. Recombinant alpha 2 interferon-related cardiomyopathy. Am J Med 1988;85:549-51.
26. Deyton LR, Walker RE, Kovacs JA, Herpin B, Parker M, Masur H, et al. Reversible cardiac dysfunction associated with interferon alpha therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med 1989;321:1246-9.
27. Sonnenblick M, Rosenmann D, Rosin A. Reversible cardiomyopathy induced by interferon. Br Med J 1990; 300:1174-5.